doxorubicin market growth

The rising demand for minimally invasive (MI) surgical procedures and the growing geriatric population, who often cannot undergo significant surgeries, have led to an increased preference for doxorubicin (DOX) in cancer treatment therapies, driving doxorubicin market growth.